CDK4/6 inhibitors synergize with radiotherapy to prime the tumor microenvironment and enhance the antitumor effect of anti-PD-L1 immunotherapy in triple-negative breast cancer
Wen-Chi Yang(National Taiwan University), Sung‐Hsin Kuo(National Taiwan University Hospital)
Cited by 3
Related Papers
Novel Insights of Lymphomagenesis of Helicobacter pylori-Dependent Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
|Cancers|2019|42
MAP3K1 expression is associated with progression and poor prognosis of hormone receptor-positive, HER2-negative early-stage breast cancer
|Cellular Oncology|2023|17
Atorvastatin Attenuates Radiotherapy‐Induced Intestinal Damage through Activation of Autophagy and Antioxidant Effects
|Oxidative Medicine and Cellular Longevity|2022|15